View of A NEXT-GENERATION ARTIFICIAL INTELLIGENCE-DESIGNED ANTIBODY AGAINST TUMOR NECROSIS FACTOR-LIKE LIGAND 1A FOR INFLAMMATORY BOWEL DISEASE: CURRENT STATUS AND FUTURE PERSPECTIVES

Return to Article Details A NEXT-GENERATION ARTIFICIAL INTELLIGENCE-DESIGNED ANTIBODY AGAINST TUMOR NECROSIS FACTOR-LIKE LIGAND 1A FOR INFLAMMATORY BOWEL DISEASE: CURRENT STATUS AND FUTURE PERSPECTIVES Download Download PDF